Physician profile
Edward D King
NPI 1205834728
$37,349.25
in general payments reported to CMS, 2019-2025
61 companies · $3,588 in 2025
The $3,588 reported for 2025 was more than what 88% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,387 · 2020: $5,181 · 2021: $5,703 · 2022: $8,763 · 2023: $5,495 · 2024: $4,233 · 2025: $3,588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,850 · Travel and Lodging: $2,359 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,013 · Education: $93.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,849.86 |
| Travel and Lodging | $2,358.78 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,012.50 |
| Education | $93.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laser Specialty Medical, LLC | $9,500.00 | 2019-2021 | |
| Sn Holdings, LLC | $4,946.88 | 2022-2023 | |
| Coloplast Corp | $2,609.41 | 2019-2025 | Titan |
| Janssen Biotech, INC. | $2,600.16 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Medtronic, INC. | $2,514.96 | 2022-2024 | Interstim, Intellis Adaptivestim |
| Teleflex LLC | $1,678.65 | 2021-2024 | Urolift, Solesta |
| Astellas Pharma US INC | $1,678.47 | 2019-2025 | Xtandi, Myrbetriq |
| Dendreon Pharmaceuticals LLC | $1,536.04 | 2019-2025 | Provenge |
| Myriad Genetic Laboratories, INC. | $1,083.39 | 2021-2025 | Prolaris |
| Pfizer INC. | $976.17 | 2019-2025 | |
| Ferring Pharmaceuticals INC. | $696.63 | 2019-2025 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $695.20 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $614.77 | 2020-2023 | Lynparza |
| Procept Biorobotics Corporation | $606.01 | 2020-2025 | Aquabeam System |
| Telix Pharmaceuticals | $555.48 | 2023-2025 | Illuccix |
Show all 60 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $434.38 | 2023-2025 | Orgovyx, Gemtesa |
| Myovant Sciences INC. | $393.84 | 2021-2022 | |
| Antares Pharma, INC. | $285.51 | 2019-2021 | |
| Tolmar Pharmaceuticals, INC. | $282.77 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $219.57 | 2021-2024 | Yonsa |
| Novartis Pharmaceuticals Corporation | $218.08 | 2019-2025 | |
| Boston Scientific Corporation | $207.02 | 2019-2025 | Spaceoar Vue System - 10ml, Ams 800 Artificial Urinary Sphincter |
| Axonics, INC. | $204.68 | 2020-2024 | Axonics, Bulkamid |
| Bioprotect Medical, INC. | $195.04 | 2024-2025 | Bioprotect Balloon Implant System |
| Endo Pharmaceuticals INC. | $192.80 | 2019-2023 | Xiaflex, Aveed |
| Abbvie INC. | $177.09 | 2019-2025 | |
| Medtronic USA, INC. | $162.39 | 2020 | |
| Blue Earth Diagnostics | $153.42 | 2019-2025 | Posluma |
| Laborie Medical Technologies Corp. | $147.51 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Tempus Ai, INC | $143.53 | 2025 | Xt Cdx |
| Urovant Sciences INC | $128.62 | 2021-2022 | |
| Amgen INC. | $127.93 | 2019-2025 | Krystexxa |
| Emd Serono, INC. | $124.99 | 2020 | |
| Merck Sharp & Dohme LLC | $104.12 | 2022-2025 | Keytruda, Lynparza |
| Angiodynamics, INC. | $102.80 | 2025 | Nanoknife |
| 180 Medical, INC. | $95.63 | 2020-2022 | |
| Foundation Medicine, INC. | $93.30 | 2020-2023 | |
| Agiliti Surgical, INC. | $92.96 | 2023 | Sonablate, Greenlight Xps |
| Urogen Pharma, INC. | $92.28 | 2021-2025 | |
| Accord Healthcare, INC. | $83.26 | 2023-2025 | |
| Integra Lifesciences Corporation | $77.58 | 2021 | |
| Verity Pharmaceuticals INC. | $61.42 | 2022-2025 | Trelstar |
| Dentsply Ih INC. | $48.07 | 2019-2020 | |
| Allergan, INC. | $46.23 | 2020-2021 | |
| Metuchen Pharmaceuticals | $41.09 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $29.73 | 2019 | |
| Olympus America INC. | $28.87 | 2019-2020 | |
| Smith+Nephew, INC. | $26.91 | 2021-2025 | Stravix |
| Calyxo, INC. | $26.33 | 2025 | Cvac Aspiration System |
| Photocure INC | $25.51 | 2024 | Cysview |
| C. R. Bard, INC. & Subsidiaries | $25.42 | 2020 | |
| Alnylam Pharmaceuticals INC. | $22.79 | 2025 | Givlaari |
| Tolmar, INC. | $20.81 | 2023 | |
| Immunitybio, INC. | $19.58 | 2025 | |
| Progenics Pharmaceuticals, INC. | $19.54 | 2025 | |
| Profound Medical Corp. | $15.67 | 2023 | Tulsa-Pro |
| Acerus Pharmaceuticals Corporation | $15.51 | 2021 | |
| Rochester Medical Corporation | $15.04 | 2022 | |
| Cardinal Health 414 LLC | $14.94 | 2025 | |
| Cook Medical LLC | $12.47 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$136,647.15 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.